Vitamin D efficacy and safety

Archives of Internal Medicine

Volumn 171, Issue 3, 2011, Pages 266-

  Heaney, Robert P ^a   Vieth, Reinhold ^b   Hollis, Bruce W ^c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; HYDROCORTISONE; THYROXINE; VITAMIN D;

COGNITION; CYTOLOGY; DNA LIBRARY; DRUG EFFICACY; DRUG SAFETY; LETTER; MACROPHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TISSUE SPECIFICITY; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT;

AGED; ALZHEIMER DISEASE; CALCITRIOL; COGNITION DISORDERS; DRUG TOXICITY; HUMANS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951529816     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.528     Document Type: Letter

References (3)

1. Grey A, Bolland M. Vitamin D: a place in the sun? Arch Intern Med. 2010;170(13):1099-1100.
2. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770- 1773.
3. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135-1141.